Heart institute seeing patients with rare condition possibly linked to mRNA vaccines - Action News
Home WebMail Tuesday, November 26, 2024, 02:59 AM | Calgary | -14.9°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Ottawa

Heart institute seeing patients with rare condition possibly linked to mRNA vaccines

The University of Ottawa Heart Institute has admitted at least eight people with a rare condition called myocarditis that maybe linked to the two mRNA vaccines produced by Moderna and Pfizer-BioNTech.

Myocarditis is an often mild inflammation of the heart muscle

At least eight people have been admitted to the University of Ottawa Heart Institute with a rare inflammation of the heart muscle known as myocarditis. Most cases of myocarditis are considered low-risk. (Ryan Remiorz/The Canadian Press)

The University of Ottawa Heart Institute has admitted at least eight people with a rare condition that maybe linked to the two mRNA vaccines produced by Moderna and Pfizer-BioNTech.

The condition, myocarditis, is an inflammation of the heart muscle.

The most common symptoms are chest pain, trouble breathing and sensations of pressure on the chest.Most cases are considered mild, with the condition often going away on its own.

In the unlikely casethat the inflammation affectsthe heart's ability to pump blood, the patient is given anti-inflammatory drugs or steroids.

"We have several new cases," said Dr. Peter Liu, scientific director of the Ottawa Heart Institute.

"And as the vaccination effort increases, we probably will see more cases."

An Ontario Public Health report shows that any sort of post-vaccine complications, however, areexceedingly rare. For every 100,000 doses administered in Ottawa, roughly 34 peoplereport adverse events a little more than 0.03 percent.

Caroline Quach, is the past chair of the National Advisory Committee in Immunization, said most vaccine-related reports of myocarditis involve men younger than 30 after they've received their second dose.

A woman walks out of the University of Ottawa Heart Institute last May. The institute has recently admitted eight people with myocarditis, or inflammation of the heart muscle a rare condition potentially connected to mRNA vaccines. (Trevor Pritchard/CBC)

Vaccine benefits outweigh risks, experts urge

Men typically experience myocarditis at a higher rate than women.So far, Ontario Public Health isn't noticing that myocarditis is occurring at ahigher rate in vaccinated men than what would normally occur in the general population.

While researchers don't yet know whether mRNA vaccines cause the rare condition, Quach said the timing suggests they appear to be related.

"There seems to be a temporal link between administration of the mRNA vaccines particularly the second dose and the development of this inflammation of the heart," she said.

"Up until now, it was a minority of cases that needed to be admitted to hospitals," Quach added. "Most of the time, we were admitting these patients for observation more than anything else."

Experts continue to stress that benefits of vaccination outweigh the risks, and Liu said all the Ottawa patients improved fairly quickly.

But he also said it's important to know about any side effects that do exist.

"Be aware of them, so that when they do occur, the individual can alert their health providers or go to the emergency department," Liusaid.

An Ottawa Public Health (OPH) spokesperson said adverse reactions to the vaccine are reported to OPH andit entersthedata in the provincial reporting system.

Corrections

  • A previous version of this story referred to Caroline Quach as the chair of the National Advisory Committee on Immunization. She is in fact the past chair.
    Jul 06, 2021 6:33 AM ET

Add some good to your morning and evening.

More than the headlines. Subscribe to You Otta Know, the CBC Ottawa weekly newsletter.

...

The next issue of You Otta Know will soon be in your inbox.

Discover all CBC newsletters in theSubscription Centre.opens new window

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.